Trade Summary

2 weeks ago, Pham Quang X, serving as CEO and Chairman at Cadrenal Therapeutics, Inc. (CVKD), sold 12,763 shares at $5.44 per share, for a total transaction value of $69,450.97. Following this transaction, Pham Quang X now holds 182,161 shares of CVKD.

This sale represents a 6.55% decrease in Pham Quang X's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 29, 2026 at 4:30 PM ET, 18 days after the trade was made.

Cadrenal Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.